CD14
apolipoprotein CIII
atherosclerosis
monocytes
thrombosis
tissue factor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
22 Jan 2023
22 Jan 2023
Historique:
received:
30
09
2022
revised:
16
01
2023
accepted:
18
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
Apolipoprotein CIII (ApoCIII) represents a key regulator of plasma lipid metabolism and a recognized risk factor for atherosclerosis and cardiovascular diseases. Beyond the regulation of lipoprotein trafficking, ApoCIII is also involved in endothelial dysfunction and monocyte recruitment related to atherothrombosis. With tissue factor (TF) being the primary initiator of the blood coagulation cascade, we hypothesized that ApoCIII-treated monocytes could express it. Hence, human CD14
Identifiants
pubmed: 36768547
pii: ijms24032223
doi: 10.3390/ijms24032223
pmc: PMC9916694
pii:
doi:
Substances chimiques
Apolipoprotein C-III
0
Apolipoproteins
0
RNA, Messenger
0
Thromboplastin
9035-58-9
CD14 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Association for Cancer Research
ID : IG-20339
Organisme : Ministry of Education, Universities and Research
ID : 20177J4E75_004
Organisme : Fondazione Cariverona
ID : B36J16002570003
Références
Lancet Haematol. 2017 Feb;4(2):e83-e93
pubmed: 28089655
Expert Rev Vaccines. 2007 Oct;6(5):835-47
pubmed: 17931162
J Am Heart Assoc. 2013 Nov 15;2(6):e000440
pubmed: 24242684
Front Cardiovasc Med. 2022 Jan 11;8:813984
pubmed: 35087886
Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):20-6
pubmed: 9445251
Circulation. 2006 Aug 15;114(7):681-7
pubmed: 16894036
J Thromb Haemost. 2010 Mar;8(3):463-71
pubmed: 20002542
Eur Heart J. 2013 Feb;34(8):615-24
pubmed: 22927557
Nat Immunol. 2022 May;23(5):679-691
pubmed: 35484408
Mol Biol Rep. 2021 Jan;48(1):875-886
pubmed: 33389539
Trends Cardiovasc Med. 2016 May;26(4):297-303
pubmed: 26877187
Nat Commun. 2015 Jan 23;6:6061
pubmed: 25616107
Lipids Health Dis. 2016 Sep 13;15(1):153
pubmed: 27619170
J Clin Lipidol. 2015 Jul-Aug;9(4):498-510
pubmed: 26228667
J Am Heart Assoc. 2019 Jan 22;8(2):e010973
pubmed: 30646800
Circulation. 2008 Aug 12;118(7):731-42
pubmed: 18663085
Thromb Haemost. 2019 Feb;119(2):192-202
pubmed: 30602199
Front Biosci (Elite Ed). 2012 Jan 01;4(1):289-99
pubmed: 22201871
Cell Rep. 2021 May 18;35(7):109143
pubmed: 34010659
J Allergy Clin Immunol. 2017 Jan;139(1):352-355.e6
pubmed: 27567327
Anal Chem. 2013 Mar 5;85(5):2867-74
pubmed: 23368640
Metabolism. 2020 Dec;113:154395
pubmed: 33058850
Nat Immunol. 2020 Jan;21(1):30-41
pubmed: 31819254
Proteomics Clin Appl. 2019 May;13(3):e1800023
pubmed: 29992792
Antimicrob Agents Chemother. 1974 Oct;6(4):422-5
pubmed: 4157338
Clin Epidemiol. 2019 Jul 22;11:625-633
pubmed: 31413640
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):183-189
pubmed: 27979856
Int J Cardiol. 1994 Dec;47(1 Suppl):S21-5
pubmed: 7737748
Nat Rev Nephrol. 2020 Mar;16(3):131
pubmed: 31853009
J Thromb Haemost. 2007 Jun;5(6):1097-105
pubmed: 17567444
Clin Sci (Lond). 2008 May;114(10):611-24
pubmed: 18399797
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725
pubmed: 29437578